ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 682833 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 682833; 2) Community: the network communities that were significantly associated with the response to NSC 682833; 3) Molecule: the relationships between components within communities and NSC 682833; 4) MDR: the compounds that were significantly associated with the NSC 682833.

NSC Compound Enrichment Correlation
NSC 649904 Cyclopentanone, 5-[(4-morpholinyl)methyl]-2-pentylidene-, hydrochloride 0.013789112253851 0.6816784
NSC 66301 Null 0.013789112253851 0.23302188
NSC 671765 3-[2-pyrrolidino] ethoxy-17-butyl-17-aza-1,3,5(10)-estratriene-16,17.alpha.-dione 0.013789112253851 0.30633527
NSC 674268 Null 0.013789112253851 0.21863529
NSC 678040 Methanone, (tricyclo[3.3.1.1(3,7)]decan-1-yl) [3-(3-nitrophenyl)-2-oxiranyl]- 0.013789112253851 -0.06952592
NSC 681632 Camptothecin Derivative 0.013789112253851 0.078580019
NSC 117281 ANTINEOPLASTIC-117281 0.0171490505199911 0.25460552
NSC 166588 METHYLUNDECYLPIPERIDINE, TRANS 0.0171490505199911 0.44127942
NSC 332837 Carbamothioic acid, dimethyl-, S-[2-(2,6-dichlorophenyl)-1-oxo-1H-inden-3-yl] ester 0.0171490505199911 0.65841821
NSC 603555 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(4-phenoxy phenyl)-, hydrochloride 0.0171490505199911 0.70681922
Total:90  Current:39    [First] [Prev] [Next] [Last]